TRxADE HEALTH, Inc. (MEDS)
USD 7.59
(4.55%)
USD 7.59
(4.55%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 11.99 Million USD | 256.1% |
| 2022 | 3.36 Million USD | 68.7% |
| 2021 | 1.99 Million USD | 79.25% |
| 2020 | 1.11 Million USD | -22.2% |
| 2019 | 1.43 Million USD | 3.5% |
| 2018 | 1.38 Million USD | 48.8% |
| 2017 | 929.4 Thousand USD | -37.42% |
| 2016 | 1.48 Million USD | -15.65% |
| 2015 | 1.76 Million USD | 217.99% |
| 2014 | 553.67 Thousand USD | 102.81% |
| 2013 | 273 Thousand USD | 169.78% |
| 2012 | 101.19 Thousand USD | 0.0% |
| 2008 | 48.69 Million USD | 239975.92% |
| 2007 | 20.28 Thousand USD | 479.54% |
| 2006 | 3500.00 USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 3.06 Million USD | -1.84% |
| 2024 Q1 | 3.12 Million USD | -73.98% |
| 2023 FY | 11.99 Million USD | 256.1% |
| 2023 Q2 | 5.03 Million USD | 48.98% |
| 2023 Q1 | 3.38 Million USD | 0.46% |
| 2023 Q4 | 11.99 Million USD | 18.79% |
| 2023 Q3 | 10.09 Million USD | 100.3% |
| 2022 Q2 | 3.86 Million USD | 31.0% |
| 2022 Q4 | 3.36 Million USD | 1.03% |
| 2022 FY | 3.36 Million USD | 68.7% |
| 2022 Q1 | 2.95 Million USD | 47.93% |
| 2022 Q3 | 3.33 Million USD | -13.84% |
| 2021 Q2 | 1.1 Million USD | -25.65% |
| 2021 FY | 1.99 Million USD | 79.25% |
| 2021 Q1 | 1.49 Million USD | 33.95% |
| 2021 Q4 | 1.99 Million USD | 122.57% |
| 2021 Q3 | 896.8 Thousand USD | -19.14% |
| 2020 Q2 | 1.58 Million USD | -13.92% |
| 2020 FY | 1.11 Million USD | -22.2% |
| 2020 Q1 | 1.83 Million USD | 28.32% |
| 2020 Q3 | 1.02 Million USD | -35.04% |
| 2020 Q4 | 1.11 Million USD | 8.44% |
| 2019 Q3 | 1.96 Million USD | -16.0% |
| 2019 FY | 1.43 Million USD | 3.5% |
| 2019 Q1 | 2.08 Million USD | 50.51% |
| 2019 Q2 | 2.33 Million USD | 12.33% |
| 2019 Q4 | 1.43 Million USD | -27.12% |
| 2018 Q1 | 873.11 Thousand USD | -6.06% |
| 2018 FY | 1.38 Million USD | 48.8% |
| 2018 Q3 | 905.4 Thousand USD | 8.66% |
| 2018 Q2 | 833.25 Thousand USD | -4.57% |
| 2018 Q4 | 1.38 Million USD | 52.74% |
| 2017 FY | 929.4 Thousand USD | -37.42% |
| 2017 Q2 | 1.06 Million USD | -14.37% |
| 2017 Q3 | 1.02 Million USD | -2.91% |
| 2017 Q1 | 1.23 Million USD | -16.65% |
| 2017 Q4 | 929.4 Thousand USD | -9.7% |
| 2016 Q2 | 2.28 Million USD | 20.06% |
| 2016 FY | 1.48 Million USD | -15.65% |
| 2016 Q4 | 1.48 Million USD | -47.83% |
| 2016 Q3 | 2.84 Million USD | 24.69% |
| 2016 Q1 | 1.9 Million USD | 8.01% |
| 2015 Q3 | 972.3 Thousand USD | -10.05% |
| 2015 Q2 | 1.08 Million USD | 76.75% |
| 2015 Q1 | 611.6 Thousand USD | 10.46% |
| 2015 FY | 1.76 Million USD | 217.99% |
| 2015 Q4 | 1.76 Million USD | 81.08% |
| 2014 Q1 | 333.78 Thousand USD | 22.27% |
| 2014 Q3 | 327.72 Thousand USD | -18.83% |
| 2014 Q2 | 403.77 Thousand USD | 20.97% |
| 2014 FY | 553.67 Thousand USD | 102.81% |
| 2014 Q4 | 553.67 Thousand USD | 68.95% |
| 2013 Q4 | 273 Thousand USD | 0.0% |
| 2013 FY | 273 Thousand USD | 169.78% |
| 2013 Q1 | - USD | 0.0% |
| 2012 FY | 101.19 Thousand USD | 0.0% |
| 2009 Q2 | 63.13 Thousand USD | 4.25% |
| 2009 Q1 | 60.56 Thousand USD | -99.88% |
| 2009 Q3 | 60.16 Thousand USD | -4.71% |
| 2008 Q2 | 32.82 Thousand USD | 25.07% |
| 2008 Q3 | 36.3 Thousand USD | 10.59% |
| 2008 Q4 | 48.69 Million USD | 134036.73% |
| 2008 FY | 48.69 Million USD | 239975.92% |
| 2008 Q1 | 26.24 Thousand USD | 29.41% |
| 2007 Q3 | 12.32 Thousand USD | 4.4% |
| 2007 Q4 | 20.28 Thousand USD | 64.56% |
| 2007 Q2 | 11.8 Thousand USD | 0.0% |
| 2007 FY | 20.28 Thousand USD | 479.54% |
| 2006 FY | 3500.00 USD | 0.0% |
| 2006 Q4 | 3500.00 USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | 5.38 Million USD | -122.575% |
| BIMI International Medical Inc. | 30.49 Million USD | 60.683% |
| China Jo-Jo Drugstores, Inc. | 80.76 Million USD | 85.154% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 241.75 Million USD | 95.04% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 241.75 Million USD | 95.04% |
| Leafly Holdings, Inc. | 34.29 Million USD | 65.035% |
| Leafly Holdings, Inc. | 34.29 Million USD | 65.035% |
| LifeMD, Inc. | 52.91 Million USD | 77.34% |
| LifeMD, Inc. | 52.91 Million USD | 77.34% |
| PetMed Express, Inc. | 78.36 Million USD | 84.699% |
| Walgreens Boots Alliance, Inc. | 68.85 Billion USD | 99.983% |